Antibiotic Resistance: Making Surgery Risky Business

Rising resistance to antibiotics could render even the most common surgeries and chemotherapy anything but routine, warns a new study in the Lancet.

The researchers estimated that for common procedures like C-sections and hip replacements, between 38-50% of pathogens causing surgical site infections and 27% of pathogens causing post-chemo infections are resistant to standard prophylactic antibiotics in the US.

Even a 30% reduction in the efficacy of antibiotics in the US could lead to 120,000 additional infections, and 6,300 infection-related deaths, according to the researchers, led by Ramanan Laxminarayan, director of the Centre for Disease Dynamics, Economics and Policy.

The Guardian

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top